ESPR icon

Esperion Therapeutics

148 hedge funds and large institutions have $426M invested in Esperion Therapeutics in 2022 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 59 increasing their positions, 41 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
148
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$22.5M
Puts
$4.14M
Net Calls
Net Calls Change

Top Buyers

1 +$11.6M
2 +$7.18M
3 +$5.25M
4
SSA
Schonfeld Strategic Advisors
New York
+$4.98M
5
Two Sigma Investments
Two Sigma Investments
New York
+$4.6M

Top Sellers

1 -$6.59M
2 -$3.37M
3 -$3.21M
4
DTC
Deep Track Capital
Connecticut
-$2.43M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$2.36M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$973K
52
$816K
53
$777K
54
$574K
55
$559K
56
$555K
57
$516K
58
$479K
59
$447K
60
$440K
61
$432K
62
$388K
63
$379K
64
$324K
65
$316K
66
$312K
67
$311K
68
$309K
69
$305K
70
$304K
71
$288K
72
$287K
73
$280K
74
$248K
75
$232K